Preeclampsia, Eve, and Adam join forces Friedrich C. Luft Clinical Implications 20 October 2005 Pages: 839 - 841
Endoproteolysis in health and diseases—implications of proprotein convertases (PCs) Michel Chrétien Editorial 08 September 2005 Pages: 842 - 843
Endo/exo-proteolysis in neoplastic progression and metastasis Abdel-Majid KhatibDaniel BassiL’Houcine Ouafik Review 26 August 2005 Pages: 856 - 864
Proprotein convertases furin and PC5: targeting atherosclerosis and restenosis at multiple levels Philipp StawowyEckart Fleck Review 22 October 2005 Pages: 865 - 875
Understanding RAGE, the receptor for advanced glycation end products Angelika BierhausPer M. HumpertPeter P. Nawroth Review 24 August 2005 Pages: 876 - 886
Preeclampsia: increased expression of soluble ADAM 12 Sabine GackAlexander MarméMarina Schorpp-Kistner Original Article 25 October 2005 Pages: 887 - 896
Topical application of plasmid DNA to mouse and human skin Nuschin MeykadehAlireza MirmohammadsadeghUlrich R. Hengge Original Article 19 May 2005 Pages: 897 - 903
T-cell-based vaccination for morphological and functional neuroprotection in a rat model of chronically elevated intraocular pressure Sharon BakalashGil Ben ShlomoMichal Schwartz Original Article 12 August 2005 Pages: 904 - 916
Clinical significance of EGFR amplification and the aberrant EGFRvIII transcript in conventionally treated astrocytic gliomas Lu LiuL. Magnus BäcklundV. Peter Collins Original Article 26 August 2005 Pages: 917 - 926
Increased plasma levels of LDL cholesterol in rabbits after adenoviral overexpression of human scavenger receptor class B type I Ivan TancevskiSasa FrankAndreas Ritsch Original Article 24 August 2005 Pages: 927 - 932
